140 related articles for article (PubMed ID: 8505641)
1. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment.
Ferner RE; Chaudhuri R; Bingham J; Cox T; Hughes RA
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):492-5. PubMed ID: 8505641
[TBL] [Abstract][Full Text] [Related]
2. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
[TBL] [Abstract][Full Text] [Related]
3. Evolution of white matter lesions in neurofibromatosis type 1: MR findings.
Sevick RJ; Barkovich AJ; Edwards MS; Koch T; Berg B; Lempert T
AJR Am J Roentgenol; 1992 Jul; 159(1):171-5. PubMed ID: 1609692
[TBL] [Abstract][Full Text] [Related]
4. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
Magnaldi S; White RM; Bryan RN
Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.
Joy P; Roberts C; North K; de Silva M
Dev Med Child Neurol; 1995 Oct; 37(10):906-14. PubMed ID: 7493724
[TBL] [Abstract][Full Text] [Related]
6. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
Mirowitz SA; Sartor K; Gado M
AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
[TBL] [Abstract][Full Text] [Related]
7. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.
Menor F; Marti-Bonmati L; Arana E; Poyatos C; Cortina H
Eur J Radiol; 1998 Jan; 26(2):121-31. PubMed ID: 9518221
[TBL] [Abstract][Full Text] [Related]
10. [Neurofibromatosis type I (NF1): peculiarities and complications].
Pascual-Castroviejo I
Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
[TBL] [Abstract][Full Text] [Related]
11. The management of brainstem gliomas in patients with neurofibromatosis 1.
Pollack IF; Shultz B; Mulvihill JJ
Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565
[TBL] [Abstract][Full Text] [Related]
12. The significance of MRI abnormalities in children with neurofibromatosis.
Duffner PK; Cohen ME; Seidel FG; Shucard DW
Neurology; 1989 Mar; 39(3):373-8. PubMed ID: 2494565
[TBL] [Abstract][Full Text] [Related]
13. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
[TBL] [Abstract][Full Text] [Related]
14. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
15. MRI findings in children with neurofibromatosis type 1: a prospective study.
Van Es S; North KN; McHugh K; De Silva M
Pediatr Radiol; 1996 Jul; 26(7):478-87. PubMed ID: 8662066
[TBL] [Abstract][Full Text] [Related]
16. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
Mirowitz SA; Sartor K; Gado M
AJNR Am J Neuroradiol; 1989; 10(6):1159-63. PubMed ID: 2512777
[TBL] [Abstract][Full Text] [Related]
17. Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1.
Jandhyala NR; Garcia MR; Kim M; Yohay K; Segal D
Pediatr Neurol; 2024 Jul; 156():66-71. PubMed ID: 38733856
[TBL] [Abstract][Full Text] [Related]
18. Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1.
Margari L; Presicci A; Ventura P; Maria Bacca S; Iliceto G; Medicamento N; Buttiglione M; Perniola T
J Child Neurol; 2006 Dec; 21(12):1085-90. PubMed ID: 17156707
[TBL] [Abstract][Full Text] [Related]
19. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
DeBella K; Poskitt K; Szudek J; Friedman JM
Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
[TBL] [Abstract][Full Text] [Related]
20. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
